Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma.
about
cFLIP overexpression in T cells in thymoma-associated myasthenia gravisPostoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies.Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinomaReproducibility of the WHO classification of thymomas: practical implicationsClinicopathological analysis of 241 thymic epithelial tumors-experience in the Shanghai Chest Hospital from 1997-2004.Entire hemithorax irradiation for Masaoka stage IVa thymomas.Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.WHO types A and AB thymomas: not always benign.Surgical treatment of thymoma: an 11-year experience with 761 patients.Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c.Assessment of Mediastinal Tumors Using SUVmax and Volumetric Parameters on FDG-PET/CT.Can 18F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors.Spontaneous thymoma in a juvenile cynomolgus macaque (Macaca fascicularis).Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.High CTLA-4 expression correlates with poor prognosis in thymoma patients.[Advances on diagnosis and treatment of malignant thymic tumors].
P2860
Q28389001-B7C31C6B-4D69-4FDA-9B63-464677DE73E7Q36103981-91DB6AE9-2BCD-433E-A896-308CB550E707Q36121712-5E4C2DFF-005D-462F-A857-D312A889CB33Q36617625-F1B18B86-78E6-406B-8F45-666CC3C00714Q36777810-3EAC841E-D557-4964-9D8E-ED44A3F24052Q37392394-786C660E-2DBF-4DFF-B9E7-0939C9085554Q37440960-88C53DB5-4DE1-4688-BAD2-43729CE3BF2EQ37787739-A1A9FB07-60C5-4DB2-908E-36D10F64480AQ38577763-64227E26-5B11-4050-861F-0C55B434EAB2Q39034212-0B028E13-4AB4-4522-A107-6331825DFE1EQ41026685-732A833C-8B2E-4BE3-8A29-7AD1B64BF7A0Q47105093-42A048DD-5E37-425E-A2CF-0C4A60DCAD87Q51465615-3E065970-F054-4A36-BB19-BC46FDCFC32BQ52985025-26628F21-5CAE-4F53-9344-DBEB7B2B083BQ53076964-C45E0E07-C310-4969-84B6-6D2894BB8602Q54943060-9B217EFF-137D-4CA6-AEF5-E4509486495EQ55465359-8E343F30-2BF3-47FA-975A-10FF5FB44E9F
P2860
Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence-based pathology and t ...... s other than thymic carcinoma.
@en
Evidence-based pathology and t ...... s other than thymic carcinoma.
@nl
type
label
Evidence-based pathology and t ...... s other than thymic carcinoma.
@en
Evidence-based pathology and t ...... s other than thymic carcinoma.
@nl
prefLabel
Evidence-based pathology and t ...... s other than thymic carcinoma.
@en
Evidence-based pathology and t ...... s other than thymic carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Evidence-based pathology and t ...... s other than thymic carcinoma.
@en
P2093
Alberto M Marchevsky
Cesar Moran
Maureen F Zakowski
Robert J McKenna
Ruta Gupta
Saul Suster
P2860
P304
P356
10.1002/CNCR.23492
P407
P577
2008-06-01T00:00:00Z